review
current
knowledg
viral
deriv
membranotrop
peptid
discuss
may
use
mani
therapeut
applic
initi
discov
viral
fusion
protein
involv
mechan
viral
entri
clear
featur
mode
interact
membran
bilay
exploit
design
viral
inhibitor
well
favor
deliveri
cargo
across
cell
membran
across
bloodbrain
barrier
peptid
extens
use
purpos
provid
signific
contribut
field
describ
role
sequenc
order
close
gap
mani
function
emerg
membranotrop
peptid
past
decad
peptid
progress
achiev
increas
valu
drug
design
pharmaceut
deliveri
moreov
great
interest
dedic
identif
peptid
drug
candid
number
peptid
pharmaceut
industri
continu
grow
entir
drug
market
repres
peptid
base
drug
bioactiv
peptid
deriv
natur
sourc
discov
ration
engin
highthroughput
screen
structurebas
design
start
defin
protein
region
among
mani
peptid
play
relev
role
biolog
show
high
propens
bind
lipid
membran
due
simultan
hydrophob
amphipath
natur
class
hydrophob
peptid
character
presenc
unusu
conspicu
amount
alanin
glycin
residu
sometim
also
prolin
degre
alagli
content
uncommon
hydrophob
domain
signal
sequenc
transmembran
anchor
fact
presenc
may
account
intrins
conform
flexibl
typic
featur
membran
interact
peptid
also
aromat
residu
gener
present
domin
interact
take
place
uniqu
physicalchem
environ
watermembran
interfac
favor
interact
aromat
side
chain
phospholipid
moieti
locat
membran
interfac
contribut
insert
peptid
bilay
amphipath
key
featur
peptid
term
amphipath
gener
refer
molecul
hydrophil
hydrophob
face
peptid
amphipath
primari
structur
secondari
structur
primari
amphipath
peptid
correspond
sequenti
assembl
domain
hydrophob
residu
domain
hydrophil
residu
divid
spacer
domain
secondari
amphipath
peptid
gener
conform
state
allow
posit
hydrophob
hydrophil
residu
opposit
side
molecul
particular
amphipath
hydrophob
peptid
present
one
face
larg
aromat
residu
small
residu
alagli
distribut
amino
acid
residu
facilit
membran
interact
peptid
insert
bilay
conform
polymorph
play
key
role
fact
abil
shift
random
conform
consequ
membran
composit
peptid
concentr
emerg
common
structur
pattern
class
peptid
sever
type
membran
activ
peptid
roughli
divid
antimicrobi
peptid
viral
peptid
cell
penetr
peptid
although
differ
primari
sequenc
one
may
hypothes
common
physic
featur
could
result
share
mechan
action
essenti
determin
mani
role
play
natur
among
hydrophob
peptid
propens
membran
bind
character
high
interfaci
hydrophob
amphipath
one
deriv
envelop
viru
glycoprotein
attract
consider
attent
peptid
interfer
envelop
viru
entri
direct
physic
interact
hydrophob
surfac
present
membran
andor
fusion
protein
thu
critic
fusion
entri
viral
glycoprotein
undergo
conform
chang
consequ
either
low
endosom
ph
receptor
bind
lead
exposur
hydrophob
peptid
loop
patch
interact
destabil
one
oppos
membran
crystallograph
data
postfus
structur
viral
fusion
protein
allow
identif
character
three
differ
class
class
fusion
protein
character
trimer
hairpin
central
coiledcoil
structur
identifi
orthomyxovirus
paramyxovirus
retrovirus
filovirus
coronavirus
class
ii
fusion
protein
present
viral
envelop
prefus
dimer
convert
postfus
trimer
hairpin
compos
structur
main
repres
flavivirida
togavirida
famili
class
iii
fusion
protein
character
central
trimer
core
similar
class
two
fusion
loop
locat
tip
elong
similar
class
ii
fusion
protein
member
present
herpesvirida
rhabdovirida
famili
despit
sever
differ
mechan
entri
elicit
three
class
fusion
glycoprotein
induc
membran
fusion
similar
manner
format
analog
hairpin
structur
allow
fusion
peptid
insert
cell
membran
drive
membran
destabil
thu
viral
entri
process
hydrophob
surfac
becom
expos
character
somewhat
variabl
time
detail
physic
characterist
includ
size
shape
secondari
structur
expos
hydrophob
patch
well
natur
neighbor
polar
charg
residu
wimleywhit
interfaci
hydrophob
scale
wwih
experimentallydetermin
free
energi
scale
calcul
propens
individu
amino
acid
peptid
sequenc
partit
water
phosphatidylcholin
interfac
effect
use
identifi
fusion
peptid
viral
glycoprotein
hydropathi
analysi
allow
calcul
hydrophob
score
along
sequenc
protein
identifi
segment
propens
interact
membran
interfac
wwih
valu
calcul
assum
random
coil
peptid
partit
bilay
interfac
valu
minimum
possibl
valu
may
get
favor
peptid
bind
also
promot
increas
secondari
structur
interfaci
helic
hydrophob
moment
ihhm
physicochem
factor
import
membran
interact
secondari
structur
format
peptid
bound
membran
interfac
ihhm
describ
degre
peptid
sequenc
would
segreg
hydrophob
hydrophil
face
fold
peptid
larg
ihhm
interact
strongli
membran
helix
due
partitioningfold
coupl
even
wwih
score
posit
overal
presenc
fusion
peptid
within
ectodomain
expos
aqueou
phase
featur
share
viral
fusion
protein
constitut
absolut
requir
fusogen
activ
fusion
peptid
typic
residu
long
potenti
fold
amphipath
helic
rich
glycin
alanin
provid
high
degre
conform
flexibl
thu
structur
polymorph
strongli
depend
environ
fusion
peptid
influenza
viru
exampl
observ
random
coil
conform
differ
environ
fig
propos
three
form
physiolog
relev
peptid
may
unstructur
solut
way
target
membran
may
helic
low
concentr
may
selfassoci
higher
concentr
membran
interfac
fusion
peptid
hiv
also
undergo
conform
transit
adopt
helic
sheet
structur
depend
concentr
lipid
ionic
condit
helic
form
influenza
fusion
peptid
probabl
key
determin
promot
fusion
structur
peptid
membran
show
kink
separ
n
termin
short
c
termin
helic
togeth
form
boomerang
shape
structur
helic
arm
amphipath
bulki
hydrophob
residu
face
membran
interior
conserv
ntermin
glycin
residu
critic
fusion
correct
structur
peptid
insid
membran
fact
mutat
valin
ntermin
helix
partial
unwound
fusion
peptid
inact
actual
numer
studi
demonstr
delic
balanc
structur
essenti
membran
fusion
influenc
environment
condit
ph
ionic
strength
peptid
sequenc
presenc
absenc
dival
cation
cholesterol
content
also
lipidpeptid
ratio
instanc
studi
perform
ebola
fusion
peptid
show
conform
transit
induc
chang
peptid
lipid
ratio
membran
low
peptid
concentr
lipid
essenti
local
peptid
concentr
increas
membran
proport
drop
favor
mainli
antiparallel
structur
concentr
depend
effect
peptid
conform
might
biolog
relev
function
mean
conform
polymorph
unclear
although
believ
fundament
enabl
backbon
reorient
fusion
protein
therefor
abil
insert
variou
level
might
requir
evolv
final
stage
fusion
cascad
independ
princip
conform
organ
degre
insert
play
key
role
induc
membran
fusion
also
hypothes
fusion
domain
first
assembl
surfac
membran
later
convert
complet
fusion
aromat
residu
gener
present
fusion
peptid
may
help
overcom
energi
cost
peptid
bond
partit
membran
interact
phospholipid
moieti
locat
membran
interfac
may
also
help
stabil
insert
one
leaflet
bilay
initi
interact
extern
leaflet
thought
gener
elast
stress
drive
bilay
fusion
help
overcom
hydrat
repuls
forc
approach
bilay
orient
poorli
solvat
face
toward
extern
medium
asymmetr
insert
one
membran
monolay
may
promot
expans
polar
head
region
determin
curvatur
stress
onto
overal
lipid
bilay
creat
bulg
protrud
membran
facilit
format
lipid
contact
fuse
bilay
particular
attent
also
devot
effect
addit
membranotrop
sequenc
overal
fusogen
presenc
addit
fusogen
sequenc
evidenc
sendai
measl
sarscov
hepatit
c
viru
dengu
e
herp
viru
gb
gh
idea
singl
fusion
peptid
sole
respons
complet
membran
fusion
event
substitut
assumpt
concert
action
differ
membranotrop
region
necessari
membran
interactingperturb
activ
matter
fact
also
membran
proxim
region
pretm
play
key
role
fusion
pretm
domain
particularli
rich
aromat
residu
enabl
insert
membran
interfac
effect
therapeut
envelop
virus
still
scarc
repres
drug
develop
hiv
influenza
viru
hepat
viru
virus
still
ideal
case
prove
induc
resist
consequ
envelop
virus
effect
therapi
entri
inhibitor
repres
interest
underutil
target
peptid
propens
membran
bind
also
interfer
envelop
viru
entri
direct
physic
interact
hydrophob
surfac
present
cell
membran
andor
fusion
protein
recent
review
badani
et
al
mani
peptid
inhibitor
somewhat
hydrophob
andor
amphipath
propens
bind
bilay
membran
interfac
hydrophob
surfac
known
whether
membran
bind
directli
affect
viral
fusion
whether
interact
fusion
protein
absolut
requir
entri
inhibit
wide
accept
membran
bind
inhibitori
peptid
greatli
increas
effect
concentr
peptid
close
fusion
protein
indic
interact
membran
interact
fusion
protein
may
effect
coupl
matter
fact
potenti
numer
fusion
peptid
andor
membranotrop
peptid
deriv
protein
envelop
virus
entri
inhibitor
wide
describ
literatur
accept
view
inhibit
infect
may
due
format
inact
aggreg
fusogen
stretch
present
viral
protein
synthet
peptid
aggreg
form
consequ
abil
oligomer
mimic
mode
bind
origin
domain
partner
protein
hypothes
stabil
prefus
intermedi
prevent
merg
bilay
evid
sever
domain
essenti
membran
fusion
thu
peptid
involv
fusion
mechan
may
interfer
intramolecular
interact
sever
domain
may
repres
interest
target
design
entri
inhibitor
thu
membran
physic
properti
could
critic
import
event
drive
viral
entri
conceiv
peptid
interfer
function
viral
fusion
protein
chang
physic
chemistri
membran
direct
interact
mani
laboratori
work
unravel
mechan
action
viral
membranotrop
peptid
sever
hypothes
propos
mani
studi
suggest
multipl
mechan
may
take
place
simultan
indirect
way
interfaci
bind
peptid
affect
viral
entri
also
hypothes
selfoligomer
membran
embed
fusion
peptid
propos
respons
inhibit
studi
case
hiv
inhibit
attribut
format
structur
defin
oligomer
complex
mutant
lower
helic
content
tendenc
selfassoci
abl
inhibit
membran
fusion
variou
stage
interest
note
clinic
studi
peptid
call
virip
design
inhibitor
hiv
fusion
peptid
sequenc
abl
block
infect
target
fusion
peptid
optim
version
sequenc
prove
potent
inhibitor
target
coil
coil
sequenc
moreov
devoid
cellular
toxic
monotherapi
clinic
trial
enrol
infect
patient
show
drug
well
toler
patient
reduc
plasma
viral
load
identif
clinic
evalu
repres
first
proof
concept
membranotrop
sequenc
could
suppress
viral
replic
infect
individu
potenti
clinic
effect
hypothesi
peptid
entri
inhibitor
act
physicalchem
interact
hydrophob
surfac
expos
fusion
process
suggest
novel
approach
may
gener
rule
moreov
instead
focuss
structurebas
design
would
possibl
design
novel
hydrophobicamphipath
inhibitor
could
easili
made
proteas
resist
introduct
nonnatur
damino
acid
membran
bilay
repres
semiperm
barrier
defin
interior
individu
cell
exist
confer
cell
potenti
surviv
function
properli
nevertheless
cross
cellular
membran
remain
one
major
obstacl
proper
deliveri
therapeut
lipophil
natur
biolog
membran
restrict
direct
intracellular
deliveri
compound
wherea
small
molecul
ion
diffus
across
bilay
larger
molecul
gener
exclud
simpl
diffus
cell
differ
hydrophobicityhydrophil
lipid
membran
render
transfer
across
barrier
extrem
difficult
due
differ
solubl
notwithstand
therapeut
potenti
number
novel
molecul
pharmacodistribut
properti
hamper
possibl
reach
stage
pharmaceut
prepar
stimul
industri
interest
fact
molecul
need
deliv
intracellularli
exert
therapeut
action
insid
cytoplasm
onto
individu
organel
thu
evid
therapeut
potenti
drug
larg
depend
develop
deliveri
tool
abl
select
effici
carri
target
cell
minim
toxic
transloc
across
membran
far
less
well
understood
bind
step
signific
similar
physicochem
paramet
membran
partit
peptid
membran
transloc
peptid
novel
intrigu
hypothesi
hydrophob
peptid
partit
membran
may
also
abl
cross
cell
membran
enter
cell
therefor
peptid
may
also
cross
endotheli
layer
vivo
includ
bloodbrain
barrier
deliveri
across
cellular
membran
involv
sever
membran
reorgan
process
transient
permeabil
cell
membran
similar
one
involv
entri
virus
membran
fusion
disrupt
relat
process
although
leakag
fusion
capac
peptid
alway
correl
featuresact
membranotrop
peptid
may
depend
particular
environment
tempor
condit
sinc
membranotrop
peptid
abl
cross
membran
bilay
essenti
identifi
structur
characterist
hydrophob
peptid
know
enter
cell
membran
highlight
featur
involv
penetr
may
help
design
novel
deliveri
tool
thu
import
featur
consid
structur
requir
cellular
uptak
abil
membranotrop
peptid
interact
cell
surfac
lipid
moieti
cell
membran
complet
review
describ
bind
transloc
membran
activ
peptid
recent
publish
highlight
fact
peptid
transloc
coupl
dye
flux
grade
dye
flux
would
occur
concomit
peptid
transloc
would
explain
incomplet
dye
releas
wherea
allornon
flux
would
occur
peptid
unabl
transloc
therefor
peptid
accumul
membran
ruptur
point
reach
result
complet
dye
releas
cellpenetr
peptid
cpp
wide
use
due
capabl
transport
sever
kind
macromolecul
across
membran
bilay
vitro
vivo
cpp
short
usual
basic
amino
acid
rich
peptid
origin
protein
abl
cross
biolog
barrier
viral
tat
protein
although
uptak
mechan
cpp
still
debat
seem
involv
mainli
endocyt
pathway
trap
conjug
cargo
endosom
eventu
end
lysosom
common
enzymat
degrad
mechan
take
place
therefor
lead
limit
deliveri
therapeut
agent
intracellular
target
hydrophob
peptid
effici
travers
biolog
membran
promot
lipidmembran
reorgan
process
fusion
pore
format
involv
temporari
membran
destabil
subsequ
reorgan
may
abl
circumv
endosom
entrap
either
favor
escap
endosom
transloc
cargo
plasma
membran
directli
cytosol
idea
exploit
design
drug
deliveri
tool
call
mpg
mpg
amphipath
peptid
whose
primari
sequenc
compos
hydrophob
amino
acid
fusion
peptid
galflgflgaagstmga
associ
hydrophil
domain
deriv
nuclear
local
sequenc
nl
simian
viru
larg
antigen
pkkkrkv
hydrophil
hydrophob
segment
separ
three
aminoacid
spacer
wsq
peptid
exploit
known
properti
glycinerich
hiv
fusion
peptid
essenti
membran
fusion
activ
nl
larg
antigen
improv
nuclear
address
peptid
moment
viral
fusion
peptid
wide
exploit
applic
drug
deliveri
mileston
understand
role
hydrophob
viral
peptid
repres
sequenc
deriv
glycoprotein
h
herp
simplex
viru
type
herp
simplex
viru
hsv
import
human
pathogen
respons
signific
morbid
mortal
worldwid
character
complex
multicompon
entri
machineri
hsv
enter
host
cell
fusion
viral
envelop
either
plasma
membran
endosom
membran
entri
pathway
like
determin
viru
host
cell
factor
involv
multipl
viral
glycoprotein
cellular
receptor
cascad
molecular
interact
envelop
glycoprotein
ghgl
gb
gd
essenti
entri
process
express
abl
induc
fusion
cellular
membran
virusfre
system
ghgl
gb
constitut
core
fusion
machineri
cooper
induc
initi
lipid
destabil
end
fusion
gb
gh
contain
sever
membranotrop
sequenc
although
recent
becom
avail
crystal
structur
ghgl
complex
still
debat
whether
gh
mere
fusion
regul
play
direct
role
fusion
process
mani
studi
suggest
ghgl
complex
may
undergo
dynam
rearrang
particular
peptid
deriv
gh
ectodomain
block
viru
entri
other
abil
bind
disrupt
model
membran
gb
consid
canon
class
iii
fusion
protein
demonstr
involv
viru
attach
penetr
celltocel
spread
crystal
structur
gb
trimer
multipl
contact
protom
throughout
molecul
contribut
stabil
hypothes
gb
refold
similarli
class
fusion
protein
pack
ctermin
arm
coiledcoil
provid
drive
forc
gb
refold
prefus
postfus
conform
gb
structur
correspond
post
fusion
conform
wide
accept
gb
undergo
conform
chang
upon
variat
ph
order
bring
fusion
sever
synthet
gb
peptid
induc
fusion
larg
unilamellar
vesicl
inhibit
herp
viru
infect
crystal
structur
gb
ghgl
yet
avail
report
identif
sever
sequenc
gh
gb
abil
interact
membran
among
sequenc
also
canon
fusion
peptid
gb
although
yet
well
understood
role
play
membranotrop
sequenc
particular
glycoprotein
gh
whole
fusion
process
wide
accept
sever
region
fusion
glycoprotein
involv
local
destabil
membran
bilay
end
fusion
viral
envelop
host
cell
membran
first
select
character
group
still
peptid
highest
fusion
capabl
wide
studi
initi
identifi
use
wwih
scale
subsequ
work
allow
determin
mani
applic
sequenc
membran
fusion
viral
inhibit
drug
deliveri
twenti
residu
peptid
aa
aa
membraneperturb
domain
fig
interact
biolog
membran
implic
merg
viral
envelop
cellular
membran
peptid
contain
residu
crucial
capac
interact
destabil
target
lipid
membran
rich
hydrophob
residu
includ
glycin
leucin
alanin
aromat
residu
tryptophan
tyrosin
known
locat
preferenti
membran
interfac
peptidelipid
interact
initi
arginin
residu
locat
cterminu
fact
arginin
mutat
fusogen
activ
peptid
strongli
impair
hydrophob
domain
also
crucial
insert
membran
support
view
hydrophob
interact
fusion
protein
cellmembran
phospholipid
initi
membran
perturb
earli
stage
viral
fusion
mani
biophys
experi
perform
shown
peptid
interact
model
membran
penetr
bilay
ntermin
side
tryptophan
residu
buri
insid
bilay
adopt
helic
conform
hydrophob
residu
one
face
helix
polar
charg
residu
opposit
face
analysi
peptid
longer
shorter
sequenc
deriv
region
interact
membran
clearli
demonstr
activ
region
depend
amino
acid
sequenc
length
presenc
histidin
residu
nterminu
nativ
sequenc
strongli
increas
fusion
activ
import
singl
histidin
residu
switch
trigger
viral
fusion
also
report
virus
paramyxovirus
therefor
support
import
specif
histidin
moieti
activ
fusion
furthermor
conserv
histidin
one
fusion
loop
semliki
forest
viru
protein
found
fundament
histidin
help
initi
interact
membran
oligomer
process
hypothesi
support
fact
histidin
locat
nterminu
correct
configur
ntermin
fusion
peptid
appear
crucial
fusogen
function
sever
fusion
protein
well
locat
membran
core
peptidebilay
interact
addit
one
histidin
nterminu
suffici
make
peptid
approxim
activ
particular
addit
residu
nterminu
impair
fusion
abil
sequenc
data
publish
strongli
interact
spontan
penetr
lipidphas
insert
membran
structur
tryptophan
tyrosin
side
helix
threedimension
structur
form
amphiphil
helix
one
side
constitut
aromat
hydrophob
residu
wherea
side
form
hydrophil
small
residu
interact
aromat
ring
tryptophan
side
chain
tyrosin
import
mainten
structur
stabil
interact
membran
amphipath
believ
import
featur
membranotrop
peptid
play
crucial
role
mediat
lipidprotein
interact
bind
protein
membran
bound
hydrophob
face
amphipath
peptid
would
allow
peptid
enter
membran
interior
therebi
trigger
local
fusion
abil
penetr
deep
bilay
helix
without
caus
signific
bilay
perturb
may
help
explain
abil
perform
sever
differ
role
show
signific
inhibitori
effect
effect
appear
condit
abil
partit
membran
aggreg
within
sinc
peptid
selfassoci
aqueou
lipid
solut
possibl
bind
counterpart
gh
protein
may
also
interact
host
cell
membran
therefor
abil
moder
inhibit
viral
entri
cell
treat
first
depend
possibl
viru
find
modifi
cell
membran
still
exhibit
surfac
peptid
moreov
activ
viru
preincub
experi
indic
eventu
bind
partner
site
prefus
gh
protein
probabl
hidden
avail
interact
free
peptid
also
demonstr
analysi
gh
crystallograph
structur
ntermin
histidin
residu
proven
fundament
interact
membran
bilay
transloc
across
membran
absenc
residu
induc
similar
level
viral
inhibit
compar
full
length
peptid
substitut
valin
residu
alter
hydrophob
peptid
influenc
infect
inhibit
properti
substitut
polar
residu
serin
substanti
reduc
inhibitori
activ
recent
poli
amid
base
dendrim
function
termini
shown
inhibit
earli
stage
entri
process
like
interact
viral
envelop
glycoprotein
thu
prevent
viru
come
close
contact
cellular
membran
prerequisit
viral
intern
inhibitori
concentr
nm
respect
evid
cell
toxic
concentr
indic
function
dendrim
membranotrop
peptid
repres
promis
strategi
inhibit
virus
herpesvirida
famili
multival
display
dendrim
scaffold
result
almost
six
fold
increas
antivir
activ
two
fold
comparison
activ
dendrim
increas
activ
unsupport
peptid
cytotox
profil
measur
mtt
assay
show
peptidodendrim
toxic
vero
cell
highest
concentr
investig
antivir
test
toxic
observ
unfunction
dendrim
especi
higher
concentr
demonstr
anoth
advantag
peptid
function
inhibitori
activ
exclud
compound
ad
postentri
step
also
cell
pretreat
dendrim
deriv
indic
peptidodendrim
dendrim
abl
interfer
viral
replic
viru
gain
access
cellular
milieu
peptidodendrim
might
steric
hinder
gh
rel
domain
either
prefusogen
intermedi
conform
prevent
complet
function
interact
gh
membran
fuse
mechan
inhibit
may
involv
bind
gh
oligomer
domain
present
glycoprotein
interact
glycoprotein
present
virion
envelop
gb
gd
modif
dendrim
scaffold
membranotrop
peptid
repres
attract
strategi
design
new
class
antivir
drug
exert
effect
coupl
intrins
antivir
properti
dendrim
activ
membranotrop
peptid
potenti
develop
multifunction
scaffold
provid
therapeut
molecul
directli
deliv
target
inhibit
membran
fusion
repres
attract
target
drug
design
although
studi
need
better
defin
exact
mechan
inhibit
hydrophob
peptid
specif
natur
locat
interact
viral
target
data
obtain
suggest
hydrophob
domain
play
signific
role
membran
fusion
provid
altern
approach
develop
viral
peptid
inhibitor
outsid
classic
inhibitori
heptad
repeat
region
cellular
uptak
associ
hydrophob
amphipath
charact
provid
necessari
abil
interact
membran
lipid
form
transient
helic
structur
temporarili
affect
membran
organ
therebi
facilit
insert
membran
transloc
compar
tat
peptid
posit
charg
cpp
mainli
exploit
endocyt
pathway
cross
membran
bilay
mainli
transloc
mechan
one
amino
acid
shorter
version
fusogen
peptid
also
found
improv
endosom
releas
dnalipofectamin
lipoplex
transgen
express
human
cell
line
recent
demonstr
abl
travers
membran
bilay
transport
cytosol
sever
compound
qd
liposom
np
dendrim
protein
exampl
use
intracellular
deliveri
enhanc
provid
remain
part
paragraph
fig
qd
fluoresc
probe
intens
research
develop
broad
applic
molecular
cellular
vivo
imag
although
consider
success
achiev
use
qd
label
fix
cell
imag
cell
membran
protein
limit
progress
made
molecular
imag
insid
live
cell
insuffici
abil
travers
cell
membran
sever
author
recent
report
function
qd
posit
charg
cpp
establish
main
rout
entranc
via
endosom
uptak
therefor
escap
endosom
system
paramount
import
intern
demonstr
highli
success
involv
endocyt
pathway
minor
extent
liposom
aggreg
also
attract
great
attent
due
success
vivo
carrier
drug
enhanc
antitumor
efficaci
liposom
drug
effort
mani
research
group
direct
toward
improv
cellular
intern
liposom
addit
surfac
ligand
cell
penetr
peptid
liposom
decor
load
doxorubicin
dox
abl
penetr
insid
live
hela
cell
result
obtain
suggest
function
liposom
could
affect
uptak
mechan
liposom
intracellular
distribut
dox
releas
evid
could
use
design
carrier
control
deliveri
releas
dox
order
avoid
side
effect
associ
dox
dendrim
also
repres
promis
tool
drug
deliveri
combin
advantag
featur
nanoparticl
ideal
size
vivo
carrier
multival
polymer
materi
low
cost
tunabl
properti
biocompat
small
molecul
monodispers
detail
control
properti
surfac
modif
mean
conjug
adsorpt
biospecif
ligand
may
allow
deliveri
specif
site
modul
drug
releas
minim
toxic
effect
increas
intracellular
bioavail
thu
dendrimer
scaffold
may
promis
tool
effici
drug
deliveri
engin
littl
inform
avail
mechan
dendrim
uptak
intracellular
traffick
studi
perform
pamam
dendrim
pamam
dendrim
function
tat
indic
endocytosi
mechan
contribut
intern
intracellular
traffick
ad
tat
fail
enhanc
deliveri
effici
attach
termini
poli
amid
base
dendrim
allow
conjug
penetr
cellular
matrix
wherea
unfunction
dendrim
exclud
transloc
peptidefunction
dendrim
rapidli
taken
cell
mainli
nonact
transloc
mechan
combin
benefit
dendrim
peptid
chemistri
could
use
develop
select
carrier
could
cross
membran
effici
intern
cellular
target
mani
therapeut
drug
exclud
enter
brain
due
lack
transport
bloodbrainbarri
bbb
develop
new
strategi
enhanc
drug
deliveri
brain
fundament
diagnost
therapeut
central
nervou
diseas
cn
strategi
transport
drug
insid
cn
caus
disrupt
anatom
textur
bbb
therefor
impair
natur
function
consequ
effect
deliveri
approach
cautious
assess
consid
impact
overal
protect
function
bbb
target
deliveri
therapeut
cargo
intend
site
action
brain
appear
one
promis
noninvas
approach
overcom
bbb
combin
advantag
brain
target
high
incorpor
capac
reduct
side
effect
circumvent
multidrug
efflux
system
polystyren
nanoparticl
np
decor
surfac
show
uptak
np
brain
endotheli
cell
greater
np
without
peptid
function
np
free
move
intracellularli
importantli
decreas
np
intracellular
accumul
larg
aggreg
enhanc
np
bbb
cross
surfac
function
may
chang
np
fate
provid
good
strategi
design
promis
carrier
deliv
drug
across
bbb
treatment
brain
diseas
whether
multifunct
nanosystem
design
test
vitro
abl
properli
work
vivo
mammalian
host
fulli
grant
address
issu
vivo
studi
necessari
thu
valid
design
strategi
facilit
optim
function
although
numer
studi
show
effici
carrier
bioactiv
cargo
vitro
result
guarante
develop
use
pharmaceut
deliveri
platform
abil
cross
bbb
vivo
also
recent
evalu
administ
vivo
rat
presenc
liver
brain
detect
within
h
iv
administr
found
beyond
bbb
proxim
fig
mani
applic
drug
deliveri
confoc
microscopi
imag
show
intern
function
protein
b
liposom
c
qdot
dendrim
e
scan
electron
microscopi
imag
function
polystyren
nanoparticl
cell
neurit
toxic
effect
vivo
sinc
affect
brain
maxim
oxid
capac
mitochondri
respir
rate
data
suggest
abil
cross
bbb
repres
novel
nanocarri
system
drug
deliveri
central
nervou
system
result
open
new
possibl
direct
deliveri
drug
patient
context
theranost
might
address
treatment
sever
human
diseas
peptid
propos
drug
deliveri
system
demonstr
tat
abl
enter
tissu
vivo
mice
antp
abl
activ
endogen
cell
mice
peptid
highli
posit
charg
absorptivemedi
transcytosi
propos
transport
across
bbb
bradykinin
analogu
also
report
increas
penetr
small
molecul
transitori
open
bbb
first
viral
membranotrop
peptid
shown
potenti
deliveri
system
macromolecul
vivo
result
coupl
previou
vitro
data
support
view
enter
bbb
without
involv
endocyt
process
henc
eventu
cargo
may
immedi
complet
avail
presenc
multipl
metabol
barrier
may
restrict
applic
peptidebas
ligand
target
drug
deliveri
vivo
peptid
alon
conjug
surfac
nanocarri
subject
proteolysi
blood
system
administr
addit
bbb
also
metabol
barrier
due
presenc
variou
enzym
brain
capillari
endotheli
cell
start
degrad
h
incub
intact
peptid
still
present
h
incub
thu
hold
potenti
extend
brain
target
effici
due
resist
proteolysi
h
still
underrecogn
amino
acid
sequenc
virtu
specif
featur
play
mani
differ
role
natur
membranotrop
viral
peptid
deriv
fusion
glycoprotein
wide
studi
especi
abil
fuse
membran
mani
literatur
data
also
describ
role
besid
membran
fusion
exampl
sequenc
employ
complet
differ
purpos
fusion
membran
viral
inhibit
drug
deliveri
till
membranotrop
peptid
extens
use
mani
applic
among
drug
deliveri
system
brain
develop
new
therapi
treat
brain
patholog
bbb
repres
major
obstacl
use
potenti
drug
treat
disord
cn
due
imperm
natur
cell
membran
compart
sever
molecul
data
report
vivo
applic
brain
deliveri
support
novel
view
synthet
peptid
deriv
viral
membranotrop
sequenc
use
success
deliv
biolog
activ
substanc
insid
bbb
exact
molecular
mechan
entri
remain
establish
appear
gener
featur
membranotrop
peptid
may
use
mediat
deliveri
virtual
tissu
particular
across
bbb
convey
wide
varieti
cargo
intact
bioactiv
virtual
tissu
organ
sequenc
found
use
drug
deliveri
happen
featur
viral
fusion
peptid
indic
may
possibl
design
novel
sequenc
predetermin
characterist
use
treat
mani
diseas
howev
still
much
work
done
type
peptid
forget
mechan
perturb
membran
bilay
may
also
allow
design
new
membranotrop
peptid
abil
denatur
membran
bilay
bacteria
thu
may
add
mani
role
also
antibacteri
activ
may
repres
altern
classic
antibiot
order
combat
antibiot
resist
problem
much
vast
literatur
membranotrop
peptid
devot
singl
activ
sequenc
yet
compel
structurefunct
relationship
studi
bridg
gap
among
activ
necessari
